AnalysisNews

VYGR today

$1.72-$0.04 (-2.27%)close Nov 12, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bearish

1 hourSymmetric Triangle

15 minStrong Bearish

5 minStrong Bearish

Daily trend turns up above $1.90

Key levels

Resistance$2.29

Resistance$2.04

Support$1.68

Latest news & SEC filings

EarningsNov 6, 2026Voyager Therapeutics Posts Q3 2026 Results

EarningsNov 5, 2026Voyager Therapeutics posts smaller quarterly loss but revenue falls short

GuidanceNov 5, 2026Voyager Therapeutics extends cash runway into Q2 2028

SEC FilingNov 5, 2026Voyager Therapeutics, Inc. filed a report on a major company event (Form 8-K)

All VYGR news →

About Voyager Therapeutics

Voyager Therapeutics is a biotechnology company that develops gene therapies and other medicines for neurological diseases. Its pipeline includes treatments for Alzheimer's, Parkinson's, and Friedreich's ataxia, using its TRACER capsid platform to deliver therapies intravenously into the brain. The company also collaborates with partners such as Neurocrine, Novartis, and Alexion on additional gene therapy programs. It operates primarily in the United States.

Based on the company's 10-K filed Mar 9, 2026.

Nasdaq · Healthcare

Voyager Therapeutics, Inc. (VYGR)

$1.72-0.04 (-2.27%)
HOLDGrade: CRisk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
1.872.022.172.321.72Oct 12Oct 20Oct 28Nov 5
High1.78
Low1.70
Open1.75
Volume796K
Avg Vol985K
VWAP1.74
30d High2.47
30d Low1.72
30d Chg-29.80%
See full chart with real-time data

What Is the Price Target for VYGR?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $1.76Upside: +0.0%Confidence: 20%Method: No Coverage

Is VYGR a Buy or Sell Right Now?

38
Investability Score
HOLD12-18 months

Thesis

  • •Revenue growing -49.5% YoY with STRONG trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VYGR.

Start Free Trial →

Is VYGR Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/B

Fair Value

$6.20

25

Moat Score

NONE

2/9

Piotroski Score

-2.0

Altman Z-Score

What Is Smart Money Doing with VYGR?

Insider Signal

SELLING

0 buys / 11 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

MEDIUM

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
Carter Todd AlfredofficerBuy33,000-Nov 1, 2026
Swartz RobinofficerBuy68,250-Nov 1, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

VYGR Growth Story

Revenue YoY

-49.5%

3yr Revenue CAGR

-0.4%

EPS Growth YoY

-80.53%

FCF Growth YoY

-617.2%

Revenue Trend

STRONG

Dark Pool Trades for VYGR

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for VYGR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
20:10:39$1.721,700$$3KSELL
19:54:16$1.731,100$$2KBUY
19:50:42$1.722,600$$4KBUY
19:50:42$1.721,412$$2KBUY
19:41:14$1.7116,500$$28KSELL

5 dark pool trades shown · $$40K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Voyager Therapeutics, Inc. (VYGR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

Sign Up Free — Download AI Report PDF →

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

Compare SEPT with other platforms

SEPT vs TradingViewSEPT vs BloombergSEPT vs Unusual WhalesSEPT vs SpotGammaSEPT vs TrendSpiderAI Trading Platforms Compared
What is dark pool trading?How to read options flowGEX explainedSmart money trackingAI stock analysisEarn money on SEPT

About SEPT Investing

SEPT Investing tracks 13,000+ stocks with live charts, trend and key-level tracking, dark pool and options flow, insider and congress trades, SEC filings and news alerts.

Disclaimer: This page is for informational purposes only. It does not constitute financial advice. Past performance does not guarantee future results. Always do your own research before making investment decisions.

VYGR — frequently asked questions

What is VYGR stock price today?

Voyager Therapeutics, Inc. (VYGR) is at $1.72, down 2.27% (-$0.04) at the Nov 12, 2026 close.

Why is VYGR stock moving today?

Latest VYGR news — Nov 6, 2026: Voyager Therapeutics Posts Q3 2026 Results · Nov 5, 2026: Voyager Therapeutics posts smaller quarterly loss but revenue falls short

What do analysts rate VYGR?

Analyst ratings for VYGR: 0 Buy, 1 Hold, 0 Sell — consensus Hold.

Did VYGR beat earnings?

VYGR last reported on Nov 5, 2026: EPS -$0.40 vs -$0.42 expected — a beat of 4.8%.

Does VYGR pay a dividend?

VYGR does not currently pay a dividend.

What are VYGR support and resistance levels?

Support: $1.68. Resistance: $2.04, $2.29, $2.58.

What are insiders doing with VYGR?

Insider activity: SELLING, 0 buys and 11 sells in the last 90 days.

What is the latest news on VYGR?

Nov 6, 2026: Voyager Therapeutics Posts Q3 2026 Results · Nov 5, 2026: Voyager Therapeutics posts smaller quarterly loss but revenue falls short · Nov 5, 2026: Voyager Therapeutics extends cash runway into Q2 2028